The cell biology of systemic insulin function

VL Tokarz, PE MacDonald, A Klip - Journal of Cell Biology, 2018 - rupress.org
Insulin is the paramount anabolic hormone, promoting carbon energy deposition in the
body. Its synthesis, quality control, delivery, and action are exquisitely regulated by highly …

Update on mutations in glucokinase (GCK), which cause maturity‐onset diabetes of the young, permanent neonatal diabetes, and hyperinsulinemic hypoglycemia

KK Osbak, K Colclough, C Saint‐Martin… - Human …, 2009 - Wiley Online Library
Glucokinase is a key regulatory enzyme in the pancreatic beta‐cell. It plays a crucial role in
the regulation of insulin secretion and has been termed the glucose sensor in pancreatic …

Genotype and phenotype correlations in 417 children with congenital hyperinsulinism

KE Snider, S Becker, L Boyajian… - The Journal of …, 2013 - academic.oup.com
Context: Hypoglycemia due to congenital hyperinsulinism (HI) is caused by mutations in 9
genes. Objective: Our objective was to correlate genotype with phenotype in 417 children …

ATP-sensitive potassium channelopathies: focus on insulin secretion

FM Ashcroft - The Journal of clinical investigation, 2005 - Am Soc Clin Investig
ATP-sensitive potassium (KATP) channels, so named because they are inhibited by
intracellular ATP, play key physiological roles in many tissues. In pancreatic β cells, these …

The P446L variant in GCKR associated with fasting plasma glucose and triglyceride levels exerts its effect through increased glucokinase activity in …

NL Beer, ND Tribble, LJ McCulloch… - Human molecular …, 2009 - academic.oup.com
Genome-wide association studies have identified a number of signals for both Type 2
Diabetes and related quantitative traits. For the majority of loci, the transition from …

Molecular physiology of mammalian glucokinase

PB Iynedjian - Cellular and Molecular Life Sciences, 2009 - Springer
The glucokinase (GCK) gene was one of the first candidate genes to be identified as a
human “diabetes gene". Subsequently, important advances were made in understanding the …

Assessing the potential of glucokinase activators in diabetes therapy

FM Matschinsky - Nature reviews Drug discovery, 2009 - nature.com
Glucokinase, a unique isoform of the hexokinase enzymes, which are known to
phosphorylate d-glucose and other hexoses, was identified during the past three to four …

A comprehensive map of human glucokinase variant activity

S Gersing, M Cagiada, M Gebbia, AP Gjesing, AG Coté… - Genome Biology, 2023 - Springer
Background Glucokinase (GCK) regulates insulin secretion to maintain appropriate blood
glucose levels. Sequence variants can alter GCK activity to cause hyperinsulinemic …

Glucokinase activity in diabetes: too much of a good thing?

FM Ashcroft, M Lloyd, EA Haythorne - Trends in Endocrinology & …, 2023 - cell.com
Abstract Type 2 diabetes (T2D) is a global health problem characterised by chronic
hyperglycaemia due to inadequate insulin secretion. Because glucose must be metabolised …

The network of glucokinase-expressing cells in glucose homeostasis and the potential of glucokinase activators for diabetes therapy

FM Matschinsky, MA Magnuson, D Zelent, TL Jetton… - Diabetes, 2006 - Am Diabetes Assoc
The glucose-phosphorylating enzyme glucokinase has structural, kinetic, and molecular
genetic features that are ideal for its primary role as glucose sensor in a network of …